Rezultati
eNauka >
Results >
Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis
| Title: | Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis | Authors: | Otasevic, Vladimir; Antić, Darko A.   ; Maiti, Kausik; Cho, Heidi; Lunney, Nancy; Dabic, Darko; Learn, Chris |
Issue Date: | 2025 | Publication: | Blood (67th Annual Meeting of the American Society of Hematology (ASH), Dec 6-9, 2025, Orlando, USA) | ISSN: | 0006-4971 Blood Search Idenfier |
Publisher: | [New York] : Elsevier | Type: | Conference Paper | Collation: | vol. 146 br. Suppl 1 str. 6315-6316 | DOI: | 10.1182/blood-2025-6315 | WoS-ID: | 001669463500015 | URI: | https://enauka.gov.rs/handle/123456789/1028453 | URL: | https://ashpublications.org/blood/article/146/Supplement%201/6315/550815/Risk-of-bleeding-in-chronic-lymphocytic-leukemia | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.